Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency

.

Source: Amyloid: The Journal of Protein Folding Disorders - September 16, 2019 Category: Biochemistry Authors: Xia Wu Hui-Lei Miao Tie-Nan Zhu Jun Feng Lu Zhang Yue-Ying Mao Dao-Bin Zhou Xin-Xin Cao Jian Li Xia Wu Source Type: research